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Abstract
Despite large strides in molecular oncology, surgery remains the bedrock in the management of visceral cancer. The primacy 
of surgery cannot be understated and a mesenteric (i.e. ontogenetic) approach is particularly beneficial to patients. Heald 
greatly advanced the management of rectal cancer with his description of the anatomical foundation of total mesorectal 
excision (TME), dramatically improving outcomes worldwide with this mesenteric-based approach. Moreover, complete 
mesocolic excision (CME) based on similar principles is becoming popular. Introduced by Hohenberger, CME resembles 
TME insofar as it emphasises strictly anatomical dissection along embryological planes to detach an intact (i.e. “complete”) 
mesentery with peritoneal envelope. CME also incorporates “central” vascular ligation (CVL) which broadly correlates 
with the “D3 lymphadenectomy” of Eastern literature. As many surgeons already practise anatomical and mesenteric-based 
surgery, it is unclear how the putative benefits of CME (including CVL) arise. Herein, we argue that these may relate to a 
more extensive resection of the mesentery, and thus mesenteric tumour deposits within the connective tissue lattice of the 
mesentery, and not necessarily the lymphadenectomy alone. We believe the connective tissue interface between the bowel 
wall and mesentery provides an alternative mode of spread of pathogenic elements. Whilst this remains a suggestion only, it 
would explain the histological independence of tumour deposits and why a greater mesenterectomy could be associated with 
benefits in survival. If this argument holds, it follows that resectional surgery for digestive organ malignancy is not surgery 
of the organ itself (or lymphatics only), but also that of the contiguous mesentery.
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Introduction
Colorectal cancer is the second commonest cause of cancer 
death in the UK, posing an enormous burden to patients, 
families and the economy in general. Despite many major 
advances in screening, treatment and heightened commu-
nity awareness, 20% of patients still present with advanced 
disease. Whilst combination chemotherapy and multi-modal 
surgery (liver surgery, thoracic surgery, cytoreductive sur-
gery and hyperthermic intraperitoneal chemotherapy) can 
extend life, stage IV disease does, in general, have a poorer 
long-term prognosis. In contrast, non-metastatic cases have 
an excellent probability of local control and cure, if careful 
case selection and high-quality surgery are employed.
Despite the era of biological chemotherapy, surgery 
remains the cornerstone of treatment in the management 
of visceral cancer. Recent reports indicate that 80% of all 
cases of cancer will need surgery and some several times 
[1]. There is no doubt as to the primacy of mesenteric-based 
resectional surgery in the management of colon and rectal 
cancer [2]. Increasing data now also support the adoption 
of mesenteric-based approaches in oesophageal, gastric and 
pancreatic cancer [3].
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(“Bill”) Heald emphasised anatomical anatomical-based 
resection of the mesorectum as part of rectal resection in the 
surgical management of rectal cancer [4]. Prior to this, blunt 
extirpation of the rectum was the widespread (though not 
global) practice. Indeed in some domains, non-anatomical 
and non-mesenteric-based surgery is still practised, in par-
ticular in the emergency setting. Heald emphasised access-
ing the interface between the mesentery and fascia and sepa-
rating both sharply. The zone was termed the “Holy Plane” 
and separation of components of the plane was later termed 
“mesofascial separation” [5]. Despite initial scepticism and 
sometimes incredulity at the dramatic improvements associ-
ated with total mesorectal excision (TME), it is now widely 
accepted as the gold standard approach.
The embryological and anatomical principles of TME 
were later extended to surgery for colon cancer, which had 
experienced a worse overall outcome compared with rectal 
cancer. Professor Werner Hohenberger described complete 
(i.e. intact) mesocolic excision and central vascular ligation 
(i.e. ligation of draining veins at their junction with the supe-
rior mesenteric vein) in 2009 [6]. His group demonstrated 
that adoption of CME was associated with a reduction in the 
local recurrence (LR) rate from 6.5 to 3.6% and increased-
year cancer-related survival from 82.1 to 89.1% in Erlangen 
from 1978–1984 to 1995–2002.
What is the exact reason for these results?
Discussion
Complete mesocolic excision is described by Hohenberger 
as “a surgical technique with sharp dissection of the vis-
ceral plane from the retroperitoneal one, aiming to avoid any 
breaching of the visceral fascia layer, which potentially may 
lead to tumour spread within the peritoneal cavity”.
Some surgeons would argue that CME is simply synony-
mous with “good surgery”. Data from West et al. [7] sug-
gested, however, that only 50% of UK practice meets the 
aims of CME. This indicates that whilst CME may equate 
with “good surgery”, it is not standard practice. Increasingly, 
colorectal surgeons recognise the importance of mesofascial 
separation [5] and access the plane between mesentery and 
underlying fascia, when detaching the mesentery from the 
posterior abdominal wall. This is a requirement in good-
quality minimally invasive colorectal surgery, especially 
with a medial-to-lateral approach. We believe that as a result 
of this, the number of surgeons practicing “CME” planar 
dissection is in fact higher than the data of West et al. (who 
analysed specimens from 1997 to 2002) might suggest.
Central vascular ligation (CVL) is, however, controver-
sial, and arguably most UK, Irish and North American sur-
geons do not practise this when conducting a resection for 
tumours in the right colon. Most surgeons ligate the ileocolic 
artery close to its origin from the superior mesenteric artery 
and a handful more dissect out the superior mesenteric vein 
so as to ligate the ileocolic flush with the vein. The latter 
equates with a D2-type resection referenced in the Eastern 
literature. In CVL, the superior mesenteric vein is exposed 
near to where it passes posterior to the neck of the pancreas, 
and veins draining the right colon are ligated at this level. 
This approximates to the D3 lymphadenectomy described in 
Japanese literature [8].
Thus, since it appears that most surgeons do practice a 
mesenteric plane-based resection (albeit not all practice 
flush ligation with the superior mesenteric vein), especially 
in the laparoscopic era, could it be that the putative benefits 
of CME rest in the central vascular (D3) component? If so, 
what is the exact mechanism?
Is there an anatomical basis to the potential 
benefits of central ligation of veins 
in the surgical management of colon cancer?
CME with CVL appear to be associated with a greater lymph 
node harvest and thus lymphadenectomy, when compared 
with conventional surgery. Caution must be applied to the 
term “conventional surgery”, as this cannot be precisely 
defined. This limitation is the key flaw in any appraisal of 
the differences between CME and non-CME approaches in 
the management of colon cancer.
Notwithstanding, it makes sense that CME and CVL 
would yield a larger volume mesentery than non-CME-based 
approaches. Hohenberger himself argues that by necessity, 
CVL is inextricably linked with CME, such that a “CME”, 
by definition, includes CVL to achieve a complete excision 
of the mesentery. We do however find that distinguishing 
the terms helps descriptively (especially with the use of 
immunofluorescence to target resection of specific lymph 
nodes only).
This would in turn support the contention that CME is 
associated with a higher lymph node yield. Lymph node 
harvest (i.e. lymphadenectomy) has multiple putative ben-
efits [9]: (1) it is a specimen-based quality indicator of the 
surgical technique applied, (2) it facilitates prognostication, 
allowing administration of adjuvant therapy and (3) it may 
be therapeutic, by potentially interrupting cancer spread. 
Given the above, it is reasonable to link CME with improved 
outcomes.
But problems also arise with this argument. If one is per-
forming embryological plane CME, then the quality of the 
surgery is already high and thus CVL adds little to this as a 
quality marker.
In terms of upstaging or the “Will Rogers phenomenon” 
it is unusual to have positive central (i.e. D3) nodes with 
negative peripheral (i.e. D1 or D2) nodes. “Skip” metastases 
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probably account for 2% of lymphatic metastases at most. 
Therefore, the likelihood of correctly upstaging potentially 
missed nodes, and hence administering adjuvant chemo-
therapy, is low. The incidence of positive central nodes and 
peripheral nodes is also low.
A further problem lies in the fact that the mesentery does 
not stop at the central zone of the superior mesenteric vein. 
It continues proximally to the porta hepatis, thus explaining 
the occurrence of portal node metastases in patients with 
colorectal cancer [10]. This means that even though one may 
be achieving a potential benefit in excavating mesenteric 
tissue at the superior mesenteric vein, truly central vascular 
ligation would involve higher echelon nodes. Furthermore, 
the mesentery is fold shaped at its central zone. On the right 
side of the fold, veins draining the small intestinal mesen-
tery, right and transverse mesocolon join the superior mes-
enteric vein. On the left side, the inferior mesenteric vein 
joins the superior mesenteric vein. The splenic vein is also 
anatomically close. The CVL component of CME addresses 
the right side of the central zone. A question arises as to 
whether one should also resect mesenteric tissue on the left 
(i.e. mesocolic side) of the central zone.
The concept of lymphadenectomy interrupting the dis-
semination of cancer is probably too simplistic and the pro-
cess of metastasis is less likely to be Newtonian and ordered 
and more likely to be complex, random and multi-level in 
nature. Certainly, there is molecular evidence that metas-
tasis and primary tumour growth are two autonomous pro-
cesses [9]. It is also clear that circulating tumour cells can 
be identified in the circulation of patients at all stages of 
primary bowel cancer [11], and thus the original “seed and 
soil” hypothesis of Stephen Paget, the Halstedian basis of 
lymphadenectomy, is a gross oversimplification.
Despite this, a study by Chen and Bilchik [12] showed 
that in AJCC Stage III colon cancer, the 5-year overall sur-
vival increased from 67 to 90% (in patients with N1 disease) 
when either 1–10 lymph nodes or more than 40 nodes were 
removed, respectively. In addition, they showed that 5-year 
overall survival increased from 51 to 71% (in patients with 
N2 disease) when either 1–35 lymph nodes or when more 
than 35 nodes were removed, respectively. These improve-
ments in overall survival are similar to results obtained 
when surgery is combined with optimal adjuvant treatment. 
Although the findings of Chen and Bilchik are correlated, 
and not definitive proof, they indicate that extensive lym-
phadenectomy may improve oncological outcome. We sus-
pect that there still may be confounders in this study (for 
instance, some surgeons with higher lymph node yield may 
have performed better CME surgery) and that a more com-
plete mesenterectomy is probably the reason.
It is important to note that the exact mechanisms by 
which metastases arise have not been fully elucidated. 
Increasing data indicate that modalities of spread other 
than haematogenous or lymphatic may be important [13, 
14]. Mortality due to colorectal cancer is mainly due to the 
development of hepatic or systemic metastases. It is argued 
that hepatic metastases arise due to portal venous spread 
from a primary tumour. Systemic (non-portal) metasta-
ses are explained by both haematogenous and lymphatic 
spread, accessing the systemic circulation via the thoracic 
duct. Trans-coelomic spread (i.e. peritoneal metastases) are 
thought to arise more directly from locally advanced primary 
tumours (i.e. T4 tumours) shedding tumour cells which then 
spread inside the abdominal cavity via the redistribution 
phenomenon [15].
Isolated metastases (also termed tumour deposits) can 
be found within the mesentery [16] and are apparently (at 
least histologically) independent of blood vessels, lym-
phatic channels and nerves. Tumour deposits are potentially 
explained by recent findings related to the mesentery and 
intestine. Both are contiguous, which means they share his-
tological elements at their interface [17]. Histological ele-
ments include connective tissue and it is now established 
that the connective tissue of the wall of the intestine is in 
continuity with that of the adjacent mesentery. The con-
nective tissue platforms provide an alternative modality of 
spread of pathogenic elements [18]. Whilst this remains a 
suggestion only, it would explain the histological independ-
ence of tumour deposits. It would also explain why more 
extensive resection of the mesentery could be associated 
with putative benefits in survival. Furthermore, it is feasible 
that many mesenteric lesions that were interpreted as nodal 
metastases were in fact tumour deposits. If the last statement 
is correct, then what was originally interpreted as extensive 
lymphadenectomy was, in fact, more extensive resection of 
tumour deposits (i.e. not lymphatic metastases [19]).
Lord Moynihan famously remarked that “the surgery 
of malignant disease is not the surgery of organs, it is the 
anatomy of the lymphatic system”.
In general, whilst surgery is of course involved in the 
management of metastatic disease, the primary role and 
power of surgery relates to local control of the primary dis-
ease. It is increasingly recognised that extended mesenteric 
resection (a necessity with CME and CVL) confers a sur-
vival advantage that was earlier attributed to greater lym-
phadenectomy (in keeping with the suggestions of Moyni-
han, Jamieson and Dobson and many others).
Conclusions
Although in the surgery of malignant disease a great empha-
sis is placed on lymphadenectomy, emerging data indicate 
that the benefits of mesenterectomy may extend beyond lym-
phadenectomy alone and relate to the resection of tumour 
deposits. If this holds, then the potential benefits of CVL 
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(as part of CME) may not solely relate to extended lym-
phadenectomy, but also to extended resection of mesen-
teric tumour deposits. In keeping with this, we propose that 
Moynihan’s original assertion be edited to;
“Resectional surgery for malignant disease of abdominal 
digestive organs is not surgery of the organ itself, but also 
that of the mesenteric organ”.
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